Tenet Healthcare Corp. 10-Q Summary (Period Ended Sept 30, 2008)
Business Context and Reporting Period
Tenet Healthcare Corporation is an investor-owned health care services company operating general hospitals, specialty facilities, and related health care services. As of September 30, 2008, the company operated 53 general hospitals with 14,321 licensed beds across 12 states. This report covers the quarterly period ended September 30, 2008, and the nine-month period ended on that date. The company is currently executing strategies to improve patient volumes, manage costs, and divest underperforming assets.
Key Financial Metrics
| Metric | Three Months Ended Sept 30, 2008 | Nine Months Ended Sept 30, 2008 |
|---|---|---|
| Net Operating Revenues | $2,158 million | $6,468 million |
| Operating Income | $66 million | $207 million |
| Net Income (Loss) | $104 million | $58 million |
| Diluted EPS | $0.22 | $0.12 |
| Operating Cash Flow | N/A | $141 million |
| Cash and Cash Equivalents | $512 million | $512 million |
| Total Debt (Long-term + Current) | $4,779 million | $4,779 million |
| Shareholders' Equity | $136 million | $136 million |
Note: Net income for the three and nine months ended September 30, 2008, includes a significant non-recurring net gain of $140 million from the sale of investments (Broadlane and a joint venture interest).
Material Changes vs. Prior Period
- Revenue Growth: Net operating revenues increased 5.7% for the quarter and 6.2% for the nine-month period compared to the prior year, driven by improved managed care pricing and increased admissions.
- Profitability: The company reported a net income of $104 million for the quarter, a significant turnaround from a net loss of $59 million in the same period in 2007. This improvement is largely attributable to the $140 million gain on investment sales.
- Operating Expenses: Salaries, wages, and benefits increased due to merit increases and higher incentive compensation, partially offset by a decline in full-time headcount. Supplies expense increased due to higher costs for orthopedics and pharmaceuticals.
- Bad Debt: The provision for doubtful accounts increased to $166 million for the quarter (7.7% of revenue) and $466 million for the nine months (7.2% of revenue), reflecting continued challenges with self-pay collections.
- Discontinued Operations: Several hospitals were reclassified as discontinued operations, including the closure of Irvine Regional Hospital and the divestiture of the Tarzana campus. Losses from discontinued operations were $10 million for the quarter and $14 million for the nine months.
Guidance, Outlook, and Risks
- Outlook: Management anticipates capital expenditures for the full year 2008 to total approximately $575 million to $625 million. The company expects continued pressure from industry-wide challenges, including volume declines in certain markets and high levels of bad debt.
- Liquidity: The company maintains $512 million in cash and cash equivalents. Borrowing capacity under its $800 million revolving credit facility was limited to $460 million as of September 30, 2008, due to fixed charge coverage ratio limitations.
- Legal and Contingencies:
- Wage and Hour Lawsuits: A tentative settlement was reached in two class action wage and hour cases (Pagaduan and Falck) with a liability range of $62 million to $85 million.
- Securities Litigation: A preliminary settlement was reached in a shareholder derivative action, expected to be finalized in Q4 2008.
- IRS Disputes: The company is contesting a $204 million tax deficiency notice from the IRS regarding prior years.
- Investment Risks: The company reclassified $48 million of investments in the Reserve Yield Plus Fund from cash equivalents due to liquidity issues and recorded a $1 million loss. Additionally, $2 million of auction rate securities were impaired by $1 million due to failed auctions.
Key Facts for Investor Verification
- Non-Recurring Gains: Verify the sustainability of earnings by excluding the $140 million gain on the sale of investments (Broadlane and joint venture) from net income calculations.
- Legal Settlements: Monitor the finalization and court approval of the wage and hour lawsuit settlements, which could impact cash flow by up to $85 million.
- Bad Debt Trends: Assess the stability of the provision for doubtful accounts, which remains elevated at 7.2% of revenue for the nine-month period, driven by self-pay patient volumes.
- Liquidity Constraints: Review the company's ability to maintain compliance with its revolving credit facility covenants, particularly the fixed charge coverage ratio, given the limited borrowing capacity of $460 million.
- Divestiture Progress: Track the completion of planned hospital divestitures and the realization of proceeds from assets held for sale to fund operations and debt service.